Item 7.01 Regulation FD Disclosure

Analyst and Investor Meetings



On January 10, 2023, Biohaven Ltd. will be making an investor presentation (the
"Presentation"). A copy of the Presentation is attached as Exhibit 99.1 to this
Current Report on Form 8-K, and is incorporated herein by reference.

The information in this Current Report on Form 8-K, including the information
set forth in Exhibit 99.1, is being furnished and shall not be deemed "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits

     Exhibit Number*                                      Exhibit Description
           99.1                    Investor Presentation, dated January 2023

           104                   The cover page of this Current Report on

Form 8-K formatted as Inline


                                 XBRL.

* The XBRL instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.


                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses